Publikacje na temat skuteczności i bezpieczeństwa szczepień:

  • Ball LK, Ball R, Pratt RD. An assesment of thimerosal use in childhood vaccines. Pediatrics 2001;107(5):1147- 1154.
  • US Food and Drug Administration. Thimerosal in Vac­cines.
  • Hepatitis B vaccines: WHO position paper – July 2017.
  • Committee for Proprietary Medicinal Products (CPMP). Points to consider on the reduction, elimination or substi­tution of thiomersal in vaccines. CPMP/BWP/2517/00: 26.04.2001. http://www.ema.europa.eu/docs/en_GB/document_li­brary/Scientific_guideline/2009/09/WC500003929.pdf
  • Hepatitis B vaccines: WHO position paper – July 2017.
  • Centers for Disease Control and Prevention. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 1999; 48(26):563-565.
  • Haemophilus influenzae type b position paper – September 2013 
  • Gołoś A., Lutyńska A. Tiomersal w szczepionkach – aktualny stan wiedzy. Epidemiol. 2015; 69: 157 – 161.
  • Thimerosal in vaccines – an interim report to clinicians. American Academy of Pediatrics (AAP), Committee on Infectious Disease, Committee on Environmental Health. Pediatrics 1999;104(3 Pt 1):570-574.
  • Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: An evidence-based meta analysis of case control and cohort studies. Vaccine 2014;32(29):3623-3629.
  • Grandjean P, Weihe P, White RF et al. Cognitive deficit in 7-year-old children with prenatal exposure to methyl mercury. Neurotoxicol Teratol 1997;19(6):417-428.
  • Pneumococcal vaccines WHO position paper – 2012.
  • Clements CJ. The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine 2004; 22(15- 16):1854-1861.
  • Hurley AM, Tadrous M, Miller ES. Thimerosal-contain­ing vaccines and autism: A review of recent epidemio­logic epidemio­logic studies. J Pediatr Pharmacol Ther 2010;15(3):173- 181.
  • Hviid A, Stellfeld M, Wohlfahrt J et al. Association be­tween thimerosal-containing vaccine and autism. JAMA 2003;290(13):1763-1766.
  • Miller L, Reynolds J. Autims and vaccination – The cur­rent evidence. J Spec Pediatr Nurs 2009;14(3):166-172.
  • Diphtheria vaccine: WHO position paper – August 2017. 
  • Clarkson TW. The three modern faces of mercury. En­viron Health Perspect 2002;110 Suppl 1:11-23.
  • Pichichero ME, Cernichiari E, Lopreiato J et al. Mercury concentrations and metabolism in infants receiving vac­cines containing thiomersal: a descriptive study. Lancet 2002;360(9347):1737-1741.
  • Lewnard JA, Cobey S. Immune History and Influenza Vaccine Effectiveness. Vaccines (Basel). 2018 May 21;6(2). pii: E28. doi: 10.3390/vaccines6020028.  PubMed PMID: 29883414; PubMed Central PMCID: PMC6027411.
  • Tetanus WHO position paper, February 2017.
  • Seki Y, Onose A, Murayama T, Koide C, Sugaya N. Influenza vaccine showed a good preventive effect against influenza-associated hospitalization among elderly patients, during the 2016/17 season in Japan. J Infect Chemother. 2018  Aug 9. pii: S1341-321X(18)30230-7. doi: 10.1016/j.jiac.2018.07.013. [Epub ahead of print] PubMed PMID: 30100400.
  • Imai C, Toizumi M, Hall L, Lambert S, Halton K, Merollini K. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers. PLoS One. 2018 Jun 7;13(6):e0198685. doi: 10.1371/journal.pone.0198685. eCollection 2018 PubMed  PMID: 29879206; PubMed Central PMCID: PMC5991711.
  • Pertussis vaccines: WHO position paper – August 2015.
  • Hendriks J, Hutubessy RCW, Grohmann G, Torelli G, Friede M, Kieny MP. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability. Vaccine. 2018 Jun 27;36(28):3993-3997. doi: 10.1016/j.vaccine.2018.05.099. Epub 2018 Jun 6. PubMed PMID: 29866617.
  • Axton JHM. Six cases of poisoning after a parenteral organic mercurial compound (merthiolate). Postgrad Med J 1972;48(561):417-421.
  • Gerber JS, Offit PA. Vaccines and autism: a tale of shift­ing hypotheses. Clin Infect Dis 2009; 48(4):456-461.
  • Polio vaccines: WHO position paper – March 2016.
  • Stehr-Green P, Tull P, Stellfeld M et al. Autism and thimerosal-containing vaccines lack of consistency evi­dence for an association. Am J Prev Med 2003;25(2):101- 106.
  • Heron J, Golding J, ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: A prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004;114(3): 577-583.
  • Measles vaccines: WHO position paper – April 2017.
  • Parker S, Todd J, Schwartz B et al. Thiomersal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2005;115(1):200.
  • Price ChS, Thompson WW, Goodson B et al.: Prena­tal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010;126(4):656-664.
  • Thompson W, Price C, Goodson B et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007;357:1281-1292.
  • Verstraeten T, Davis RL, DeStefano F et al. Safety of thimerosal-containing vaccine: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003;112(5):1039-1048.
  • Orenstein WA, Paulson JA, Brady MT et al. Global vac­cination recommendations and thimerosal. Pediatrics 2013;131(1):149-151.
  • Solecka M. Is there a proven link between vaccina­tion and thiomersal? No, but…; mp.pl; Published on­line:12.03.2014 (in Polish). http://www.mp.pl/szczepienia/specjalne/show. html?id=98368
  • Verstraeten T. Thimerosal, the Centers for Disease Con­trol and Prevention, and GlaxoSmithKline. Pediatrics 2004;113(4):932.
  • Shibata N, Kimura S, Hoshino T, Takeuchi M, Urushihara H. Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database. Vaccine. 2018 May 11;36(20):2809-2815. doi: 1016/j.vaccine.2018.03.082. Epub 2018 Apr 13. PubMed PMID: 29661585.6
  • Andrews N., Miller E., Grant A., Stowe J., Osborne V., Taylor B.: Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics, 2004; 114: 584–591.
  • Baird G i wsp. Measles Vaccination and Antibody Response in Autism Spectrum Disorders. Arch Dis Child 2008; 93(10):832-7.
  • Baker J.P.: Mercury, vaccines, and autism: one controversy, three histories. Am. J. Public Health, 2008; 98: 244–253.
  • Black C i wsp. Relation of Childhood Gastrointestinal Disorders to Autism: Nested Case Control Study Using Data from the UK General Practice Research Database. BMJ 2002; 325:419-21.
  • Black S.B., Cherry J.D., Shinefield H.R., Fireman B., Christenson P., Lampert D.: Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. Am. J. Dis. Child., 1991; 145: 746–749.
  • Centers for Disease Control and Prevention: Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb. Mortal. Wkly Rep., 1999; 48: 563–565.
  • Chen R.T., DeStefano F.: Vaccine adverse events: causal or coincidental? Lancet, 1998; 351: 611–612.
  • D’Souza Y i wsp. No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells from Children with Autism Spectrum Disorder. Pediatrics 2006; 118(4):1664-75.
  • Dales L i wsp. Time Trends in Autism and in MMR Immunization Coverage in California. JAMA 2001; 285(9):1183-5.
  • Dales L., Hammer S.J., Smith N.J.: Time trends in autism and in MMR immunization coverage in California. JAMA, 2001; 285: 1183–1185.
  • Davidson M., Letson G.W., Ward J.I., et al.: DTP immunization and susceptibility to infectious diseases. Is there a relationship? Am. J. Dis. Child., 1991; 145: 750–754.
  • Demicheli V i wsp. Vaccines for Measles, Mumps and Rubella in Children. Cochrane Database Syst Rev. 2012 Feb 15.
  • DeStefano F i wsp. Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects: A Population-Based Study in Metropolitan Atlanta. Pediatrics 2004; 113(2): 259-66.
  • DeStefano F., Bhasin T.K., Thompson W.W., Yeargin-Allsopp M., Boyle C.: Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics, 2004; 113: 259–266.
  • DeWilde S., Carey I.M., Richards N., Hilton S.R., Cook D.G.: Do children who become autistic consult more often after MMR vaccination? Br. J. Gen. Pract., 2001; 51: 226–227.
  • Dingle J.H., Badger G.F., Jordan W.S. Jr: Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland: Press of Western Reserve University, 1964.
  • Doja A, Roberts W. Immunizations and Autism: A Review of the Literature. Can J Neurol Sci. 2006; 33(4):341-6.
  • Farrington C.P., Miller E., Taylor B.: MMR and autism: further evidence against a causal association. Vaccine, 2001; 19: 3632–3635.
  • Fombonne E i wsp. No Evidence for a New Variant of Measles-Mumps-Rubella Induced Autism. Pediatrics 2001;108(4):E58.
  • Fombonne E i wsp. Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links with Immunizations. 2006;118(1):e139-50.
  • Fombonne E., Chakrabarti S.: No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics, 2001; 108: E58.
  • Fombonne E., Zakarian R., Bennett A., Meng L., McLean-Heywood D.: Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics, 2006; 118: e139–e150.
  • https://www.mp.pl/szczepienia/przeglad/hpv/122525,czy-szczepionka-przeciwko-hpv-jest-skuteczna
  • Heron J., Golding J.; ALSPAC Study Team: Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics, 2004; 114: 577–583.
  • Hornig M et al. Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study. PLoS ONE 2008; 3(9):e3140.
  • Hornig M., Briese T., Buie T., et al.: Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS ONE, 2008; 3: e3140
    Sutcliffe J.S.: Genetics. Insights into the pathogenesis of autism. Science, 2008; 321: 208–209.
  • https://www.mp.pl/szczepienia/przeglad/hpv/155484,czy-2-walentna-szczepionka-przeciwko-hpv-jest-skuteczne-u-kobietw-wieku-25-lat
  • Hviid A., Stellfeld M., Wohlfahrt J., Melbye M.: Association between thimerosal-containing vaccine and autism. JAMA, 2003; 290: 1763–1766.
  • Immunization Safety Review: Adverse Effects of Vaccines: Evidence and Causality. Institute of Medicine. The National Academies Press: 2011. Consensus Report. conclusion: Evidence favors rejection of five vaccine-adverse event relationships, including MMR vaccine and autism. Overall, the committee concludes that few health problems are caused by or clearly associated with vaccines.
  • Rubella vaccines: WHO position paper – April 2017.
  • Immunization Safety Review: Vaccines and Autism. Institute of Medicine. The National Academies Press: 2004.
  • Jain A i wsp. Autism Occurrence by MMR Vaccine Status among US Children with Older Siblings with and without Autism. JAMA 2015;313(15):1534-40.
  • Kaye JA i wsp. Mumps, Measles, and Rubella Vaccine and the Incidence of Autism Recorded by General Practitioners: A Time Trend Analysis. BMJ 2001; 322:460-63.
  • Laupland K.B., Davies H.D., Low D.E., Schwartz B., Green K., McGeer A.: Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics, 2000; 105: E60 .
  • Lingam R i wsp. Prevalence of Autism and Parentally Reported Triggers in a North East London Population. Arch Dis Child 2003; 88(8):666-70.
  • Madsen K.M., Lauritsen M.B., Pedersen C.B., et al.: Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics, 2003; 112: 604–606.
  • Madsen KM i wsp. A Population-Based Study of Measles, Mumps, and Rubella  Vaccination and Autism. N Engl J Med 2002; 347(19):1477-82.
  • Makela A i wsp. Neurologic Disorders after Measles-Mumps-Rubella Vaccination. Pediatrics 2002; 110:957-63.
  • Corson S, Robertson C, Reynolds A, McMenamin J. Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: the impact of targeting all individuals aged 65 years and over Flu Vaccination Programme Effectiveness. Influenza Other Respir Viruses. 2018 Jun 16. doi: 10.1111/irv.12583. [Epub ahead of print] PubMed PMID: 29908098.
  • https://www.mp.pl/szczepienia/przeglad/hpv/182878,co-wiadomo-o-trwalosci-ochrony-po-szczepieniu-przeciwko-hpv
  • Yin M, Huang L, Zhang Y, Yu N, Xu X, Liang Y, Ni J. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines. 2018J ul;17(7):653-663. doi: 10.1080/14760584.2018.1495077. Epub 2018 Jul 16. PubMed  PMID: 29961353.
  • COMMITTEE ON INFECTIOUS DISEASES. Recommendations for Prevention and Control of Influenza in Children, 2018-2019. Pediatrics. 2018 Sep 3. pii: e20182367. doi: 1542/peds.2018-2367. [Epub ahead of print] PubMed PMID: 30177511.
  • https://www.mp.pl/szczepienia/przeglad/hpv/176826,szczepienie-przeciwko-hpv-jest-skuteczne-i-bezpieczne
  • Advisory Committee on Immunization  Practices(ACIP) https://www.cdc.gov.vaccines/acip/index.html
  • Ellebedy AH. Immunizing the Immune: Can We Overcome Influenza’s Most Formidable Challenge? Vaccines (Basel). 2018 Sep 22;6(4). pii: E68. doi: 10.3390/vaccines6040068. PubMed PMID: 30248996.
  • McCormick M.C.: Immunization safety review: vaccines and autism. Washington, DC: Institute of Medicine, 2004.
  • Morrow E.M., Yoo S.Y., Flavell S.W., et al.: Identifying autism loci and genes by tracing recent shared ancestry. Science, 2008; 321: 218–223
  • https://www.mp.pl/szczepienia/przeglad/hpv/182879,szczepienie-przeciwko-hpv-jest-skuteczne-i-bezpieczne
  • Mrozek-Budzyn D i wsp. Lack of Association Between Measles-Mumps-Rubella Vaccination and Autism in Children: A Case-Control Study. Pediatr Infect Dis J. 2010;29(5):397-400.
  • Nelson K.B., Bauman M.L.: Thimerosal and autism? Pediatrics, 2003; 111: 674–679.
  • O’Brien K.L., Walters M.I., Sellman J., et al.: Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis., 2000; 30: 784–789.
  • http://szczepienia.pzh.gov.pl/badania-potwierdzaja-dlugoterminowa-skutecznosc-szczepionki-przeciw-hpv/
  • Offit P.A., Quarles J., Gerber M.A., et al.: Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics, 2002; 109: 124–129
    King G.E., Hadler S.C.: Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr. Infect. Dis. J., 1994; 13: 394–407.
  • Parker S.K., Schwartz B., Todd J., Pickering L.K.: Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics, 2004; 114: 793–804
    Offit P.A.: Vaccines and autism revisited – the Hannah Poling case. N. Engl. J. Med., 2008; 358: 2089–2091.
  • Patja A., Davidkin I., Kurki T., Kallio M.J., Valle M., Peltola H.: Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr. Infect. Dis. J., 2000; 19: 1127–1134.
  • Peltola H., Patja A., Leinikki P., Valle M., Davidkin I., Paunio M.: No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet, 1998; 351: 1327–1328.
  • Richler J, Luyster R, Risi S i wsp. Is There a ‘Regressive Phenotype’ of Autism Spectrum Disorder Associated with the Measles-Mumps-Rubella Vaccine? A CPEA Study. J Autism Dev Disord. 2006 Apr;36(3):299-316.
  • Smeeth L i wsp. MMR Vaccination and Pervasive Developmental Disorders: A Case-Control Study. Lancet 2004; 364(9438): 963-9.
  • Stehr-Green P., Tull P., Stellfeld M., Mortenson P.B., Simpson D.: Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am. J. Prev. Med., 2003; 25: 101–106.
  • https://pediatria.mp.pl/szczepieniaochronne/szczepienia-i-szczepionki/65352,szczepienie-przeciwko-wirusowi-brodawczaka-ludzkiego-hpv
  • Storsaeter J., Olin P., Renemar B., et al.: Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. Pediatr. Infect. Dis. J., 1988; 7: 637–645.
  • Taylor B i wsp. Autism and Measles, Mumps, and Rubella Vaccine: No Epidemiological Evidence for a Causal Association. Lancet 1999;353 (9169):2026-9.
  • https://www.mp.pl/szczepienia/przeglad/hpv/177929,skutecznosc-9-walentnej-szczepionki-przeciwko-hpv-u-kobiet-w-wieku-16-26-lat
  • Taylor B i wsp. Measles, Mumps, and Rubella Vaccination and Bowel Problems or Developmental Regression in Children with Autism: Population Study. BMJ 2002; 324(7334):393-6.
  • Taylor B., Miller E., Lingam R., Andrews N., Simmons A., Stowe J.: Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ, 2002; 324: 393–396.
  • Taylor LE i wsp. Vaccines Are Not Associated with Autism: An Evidence-based Meta-analysis of Case-control and Cohort Studies. Vaccine 2014;32(29):3623–9.
  • Thompson W.W., Price C., Goodson B., et al.: Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N. Engl. J. Med., 2007; 357: 1281–1292.
  • Uchiyama T i wsp. MMR-Vaccine and Regression in Autism Spectrum Disorders: Negative Results Presented from Japan. J Autism Dev Disord 2007; 37(2):210-7.
  • Uno Y i wsp. Early Exposure to the Combined Measles-Mumps-Rubella Vaccine and Thimerosal-containing Vaccines and Risk of Autism Spectrum Disorder. Vaccine 2015;33(21):2511-6.
  • http://zdrowie.gazeta.pl/Zdrowie/7,105912,23221937,szczepionka-przeciw-wirusowi-hpv.html
  • Verstraeten T., Davis R.L., DeStefano F., et al.; Vaccine Safety Datalink Team: Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics, 2003; 112: 1039–1048.
  • National Research Council: Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press, 2004: p. 151.
  • https://www.mp.pl/szczepienia/przeglad/hpv/124958,co-wiadomo-o-skutecznosci-nowej-szczepionki-przeciwko-hpv
  • The European Agency for the Evaluation of Medicinal Products (EMEA). EMEA Public Statement on Thiomer­sal in vaccines for human use – Recent evidence supports safety of thiomersal-containing vaccines. EMEA/CPMP/ VEG/1194/04/Adopted; 24.03.2004.
  • Global Advisory Committee on Vaccine Safety (GACVS). Thiomersal in vaccines. Week Epidemiol Rec 2012;87(30):277-288. http://www.who.int/wer/en/
  • Committee for Medicinal Products for Human Use (CHMP). CHMP Position Paper on Thiomersal. Imple­mentation of the Warning Statement Relating to Sensi­tisation; EMEA/CHMP/VWP/19541/2007;11.01.2007. http://www.ema.europa.eu/docs/en_GB/document_li­brary/Scientific_guideline/2009/09/WC500003905.pdf